Metal nanoparticles: a theranostic nanotool against cancer
Language English Country Great Britain, England Media print-electronic
Document type Journal Article, Review
PubMed
26007605
DOI
10.1016/j.drudis.2015.05.009
PII: S1359-6446(15)00199-3
Knihovny.cz E-resources
- MeSH
- Metal Nanoparticles administration & dosage MeSH
- Humans MeSH
- Neoplasms diagnosis drug therapy pathology MeSH
- Antineoplastic Agents administration & dosage therapeutic use MeSH
- Drug Design MeSH
- Theranostic Nanomedicine methods MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Antineoplastic Agents MeSH
Cancer remains one of the most deadly diseases worldwide, but conventional anticancer therapies come with several drawbacks. Therefore, there is a need to develop new anticancer strategies. Theranostics is a strategy that combines treatment with diagnosis and monitoring. Metal nanoparticles are proposed as one of the most promising theranostic agents for the treatment of cancer. Thus, metals including iron, gold (Au), silver (Ag), zinc (Zn), and titanium, have potential as anticancer agents, either inherently or as a result of surface modifications. As a functional component of theranostic tools, metal nanoparticles have crucial dual roles as a diagnostic and active therapeutic agent for the treatment of cancer.
Department of Pharmaceutics Jamia Hamdard New Delhi India
Department of Wood Science Mendel University in Brno Brno Czech Republic
References provided by Crossref.org
